← Back to catalogue

Reverse-Cyte 3% (A1, B)

FDA UDI

by Medion Grifols Diagnostics AG

Identity

Trade Name
Reverse-Cyte 3% (A1, B) FDA UDI
Generic Name
Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination FDA UDI
Device Name
Reagent Red Blood Cells for confirmation of ABO Blood Grouping. For in vitro diagnostic use. FDA UDI
Model / Reference
2x10 ml FDA UDI
Description
Reagent Red Blood Cells for confirmation of ABO Blood Grouping. For in vitro diagnostic use. FDA UDI

Identifiers

Catalog Number
213635 FDA UDI
Primary DI / UDI-DI
07640137340292 FDA UDI
GMDN Term
Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination

Reverse-Cyte 3% (A1, B) by Medion Grifols Diagnostics AG — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Medion Grifols Diagnostics AG

Sources (1)

  • FDA UDI 6d006463-a191-4354-a7e9-5468a28e93f1 33 fields · synced May 30, 2026